Bill Text: TX SB584 | 2017-2018 | 85th Legislature | Comm Sub
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Relating to guidelines for prescribing opioid antagonists.
Spectrum: Partisan Bill (Democrat 5-0)
Status: (Passed) 2017-06-01 - Effective on 9/1/17 [SB584 Detail]
Download: Texas-2017-SB584-Comm_Sub.html
Bill Title: Relating to guidelines for prescribing opioid antagonists.
Spectrum: Partisan Bill (Democrat 5-0)
Status: (Passed) 2017-06-01 - Effective on 9/1/17 [SB584 Detail]
Download: Texas-2017-SB584-Comm_Sub.html
By: West, et al. | S.B. No. 584 | |
(Rose) | ||
|
||
|
||
relating to guidelines for prescribing opioid antagonists. | ||
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
SECTION 1. Subtitle B, Title 3, Occupations Code, is | ||
amended by adding Chapter 170 to read as follows: | ||
CHAPTER 170. PRESCRIPTION OF OPIOID ANTAGONISTS | ||
Sec. 170.001. DEFINITIONS. In this chapter, "opioid | ||
antagonist" and "opioid-related drug overdose" have the meanings | ||
assigned by Section 483.101, Health and Safety Code. | ||
Sec. 170.002. GUIDELINES. (a) The board shall adopt | ||
guidelines for the prescription of opioid antagonists. | ||
(b) The guidelines must address: | ||
(1) prescribing an opioid antagonist to a patient to | ||
whom an opioid medication is also prescribed; and | ||
(2) identifying patients at risk of an opioid-related | ||
drug overdose and prescribing an opioid antagonist to that patient | ||
or to a person in a position to administer the opioid antagonist to | ||
that patient. | ||
(c) In adopting guidelines under this section, the board: | ||
(1) shall consult with the Texas State Board of | ||
Pharmacy; | ||
(2) shall consult materials published by the Substance | ||
Abuse and Mental Health Services Administration of the United | ||
States Department of Health and Human Services; and | ||
(3) may consult other appropriate materials, | ||
including medical journals subject to peer review and publications | ||
by medical professional associations. | ||
Sec. 170.003. LIABILITY FOR ACT OR OMISSION WITH RESPECT TO | ||
PRESCRIBING AN OPIOID ANTAGONIST. A physician who acts in good | ||
faith and with reasonable care, regardless of whether the physician | ||
follows the guidelines adopted under this chapter, is not subject | ||
to criminal or civil liability or any professional disciplinary | ||
action for: | ||
(1) prescribing or failing to prescribe an opioid | ||
antagonist; or | ||
(2) any outcome resulting from the eventual | ||
administration of an opioid antagonist prescribed by the physician. | ||
SECTION 2. The change in law made by this Act relating to | ||
conduct that is grounds for imposition of a disciplinary sanction | ||
applies only to conduct that occurs on or after September 1, 2017. | ||
Conduct that occurs before September 1, 2017, is governed by the law | ||
in effect on the date the conduct occurred, and the former law is | ||
continued in effect for that purpose. | ||
SECTION 3. The change in law made by this Act relating to | ||
conduct that is the basis for civil liability applies only to | ||
conduct that occurs on or after September 1, 2017. Conduct that | ||
occurs before September 1, 2017, is governed by the law in effect on | ||
the date the conduct occurred, and the former law is continued in | ||
effect for that purpose. | ||
SECTION 4. The change in law made by this Act relating to | ||
conduct that constitutes a criminal offense applies only to an | ||
offense committed on or after September 1, 2017. For purposes of | ||
this section, an offense is committed before September 1, 2017, if | ||
any element of the offense occurs before that date. An offense | ||
committed before September 1, 2017, is governed by the law in effect | ||
on the date the offense was committed, and the former law is | ||
continued in effect for that purpose. | ||
SECTION 5. This Act takes effect September 1, 2017. |